Cargando…
Role of inhaled levosimendan in peripartum cardiomyopathy
Levosimendan is an inodilator agent, which was initially widely used in low contractility states. However, its use has been restricted because of the invariable need to use a vasoconstrictor like norepinephrine, since it causes a marked fall in systemic vascular resistance (SVR). Hence its beneficia...
Autores principales: | Kaur, Parminder, Kundra, Tanveer S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630672/ https://www.ncbi.nlm.nih.gov/pubmed/36337420 http://dx.doi.org/10.4103/sja.sja_297_22 |
Ejemplares similares
-
Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018) -
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan
por: Nieto Estrada, Victor H., et al.
Publicado: (2015) -
Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010) -
Management of Wolff-Parkinson-White syndrome in a patient with peripartum cardiomyopathy
por: Bendaram, Snigdha, et al.
Publicado: (2021) -
Cardiomyopathie du péripartum
por: Drissi, Jihad, et al.
Publicado: (2018)